elranatamab will enhance the stage or effect of fentanyl transdermal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Elranatamab causes cytokine release syndrome (CRS) that will suppress action of CYP enzymes, leading to improved publicity of CYP substrates.Take the medication to a medication take-again method. Test